Bevacizumab (Bevacizumab)
Overview of Bevacizumab
Bevacizumab is a multikinase inhibitor. It slows the growth of cancer cells, by blocking certain enzymes in the body that may be involved in the growth and spread of cancer cells, and spread in the body. It is usually given as part of a combination of cancer.
Indication of Bevacizumab
Bevacizumab is primarily indicated in conditions like Brain tumors, Breast cancer, Lung cancer, Metastatic colorectal cancer.
Contraindication of Bevacizumab
Bevacizumab is contraindicated in conditions like Hypertension,Wounds,Blood clot,History of stroke.
Side Effects of Bevacizumab
Bevacizumab produces potentially life-threatening effects which include Blood in stools, Sudden numbness, Blood in stoolsvomitings. which are responsible for the discontinuation of Bevacizumab therapy.,The symptomatic adverse reactions produced by Bevacizumab are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Nausea, Sweating, Chills, Itching, Light headedness, Chest pain, Wheezing, Increase in heart rate.
Precautions of Bevacizumab
Avoid having surgery while you are being treated with bevacizumab. You may have problems with wound healing, which could result in bleeding or infection. If you need to have any type of surgery, you will need to stop receiving bevacizumab for at least 4 weeks while your surgical incision heals.